12 Health Care Stocks Moving In Thursday's Pre-Market Session

 

Gainers

  • BiondVax Pharmaceuticals BVXV shares moved upwards by 55.5% to $2.13 during Thursday's pre-market session. The market value of their outstanding shares is at $39.3 million.
  • Aptorum Group APM shares rose 13.86% to $1.56. The company's market cap stands at $55.5 million.
  • HOOKIPA Pharma HOOK stock increased by 13.29% to $1.79. The market value of their outstanding shares is at $97.8 million. The company's, Q4 earnings came out today.
  • NeuBase Therapeutics NBSE shares increased by 12.69% to $2.22. The company's market cap stands at $72.7 million.
  • Lucid Diagnostics LUCD stock increased by 11.88% to $3.39. The market value of their outstanding shares is at $124.7 million.
  • MorphoSys MOR stock rose 9.46% to $7.17. The company's market cap stands at $979.3 million.

Losers

  • Hyperfine HYPR shares declined by 8.8% to $3.22 during Thursday's pre-market session. The company's market cap stands at $225.5 million. The company's, Q4 earnings came out yesterday.
  • Impel NeuroPharma IMPL shares decreased by 8.11% to $7.37. The company's market cap stands at $169.8 million. As per the press release, Q4 earnings came out today.
  • Immutep IMMP shares declined by 7.9% to $3.15. The market value of their outstanding shares is at $269.0 million.
  • GBS GBS stock decreased by 7.59% to $0.89. The market value of their outstanding shares is at $13.2 million.
  • Neogen NEOG shares decreased by 7.53% to $31.2. The company's market cap stands at $3.3 billion. As per the news, the Q3 earnings report came out today.
  • Diffusion Pharmaceuticals DFFN shares declined by 7.38% to $0.31. The market value of their outstanding shares is at $32.0 million. As per the press release, Q4 earnings came out 4 days ago. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!